Arrowhead Pharmaceuticals Faces Distribution Risks With Vanscoy Reliance

TipRanks01:00 ET

Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday

Benzinga13:10 ET

SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies

Zacks 11:00 ET

Arrowhead Pharmaceuticals Is Maintained at Neutral by Citigroup

Dow JonesNov 27 10:34 ET · Ratings

Express News | Arrowhead Pharmaceuticals Shares up 6.2% ; at Least Two Brokerages Raise PT After Licensing Deal With Sarepta

ReutersNov 27 09:36 ET

Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock.

BenzingaNov 27 08:35 ET